Patent · US Active

Nucleic acids encoding CRISPR-associated proteins and uses thereof

US11739335B2 · kind B2 · utility

5Cited by

0References

18Claims

0Family size

Assignee

CureVac SE · DE

Inventors

Frédéric CHEVESSIER-TÜNNESEN · Tübingen, DE
Marion Poenisch · Tübingen, DE
Thomas SCHLAKE · Gundelfingen, DE

Key dates

Filing date	Mar 23, 2018
Grant date	Aug 29, 2023
Priority date	—
Expiry date	Aug 30, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/531
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the field of biomedicine, and in particular to the field of therapeutic nucleic acids. The present invention provides artificial nucleic acids, in particular RNAs, encoding CRISPR-associated proteins. A (pharmaceutical) composition and kit-of-parts comprising the same are also provided. Furthermore, the present invention relates to the artificial nucleic acid, (pharmaceutical) composition, or kit-of-parts for use in medicine, and in particular in the treatment and/or prophylaxis of diseases amenable to treatment with CRISPR-associated proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.